Prostate cancer, breast cancer and enlarged hearts could be getting a new approach to treatment because of a protein called RSK. “When activated, RSK is involved in cell survival, cell proliferation and cell enlargement,” according to Loyola University Chicago Stritch School of Medicine researchers. RSK reveals properties that contribute to cancer, therefore, controlling RSK could change the face of cancer treatment.